equitybuy

ABSI

Trust-weighted public proof page for ABSI. See which authors support it, which ticker theses it belongs to, and how thesis calls have performed.

Opportunity
98 / 100
Current score
1.72
Thesis calls
4
Active decisions
3

Recent proof-backed thesis calls

Public preview of asset-level thesis calls linked to source content, observed prices, and outcomes.

Absci Corpsec_filingsopen

This excerpt is the cover/boilerplate portion of AbSci Corp’s Form 10-Q for quarter ended 2026-03-31. It confirms the filer identity, exchange listing (Nasdaq Global Select), and reporting compliance checkboxes, but contains no financial results, guidance, risks, or operational updates in the provided text—so it’s not meaningfully actionable for trading by itself.

Mentioned: May 7, 2026, 4:24 PM EDTConviction: 18 / 100
Source: ABSI 10-Q report for 2026-03-31
Absci Corpsec_filingsopen

Extractable information is limited to the 10-K cover page for AbSci Corporation (ABSI): filer identity, fiscal year-end (2025-12-31), SEC registrant status, and Nasdaq Global Select Market listing. No business/financial performance, guidance, risks, liquidity, or outlook details are included in the provided excerpt, so actionable trading implications are minimal.

Mentioned: Mar 24, 2026, 4:30 PM EDTConviction: 18 / 100
Source: ABSI 10-K report for 2025-12-31
Absci Corpsec_filingsopen

The provided text is only the cover/header portion of Absci Corporation’s Form 10‑Q for the quarter ended 2025‑09‑30 (filing/registration details, exchange, symbol, compliance checkboxes). It contains no financial statements, MD&A, guidance, risk updates, cash runway, or operational milestones—so there is no concrete, tradeable fundamental signal in the excerpt.

Mentioned: Nov 12, 2025, 4:13 PM ESTConviction: 18 / 100
Source: ABSI 10-Q report for 2025-09-30
Absci Corpsec_filingsopen

Excerpt is the cover/header of ABSCI Corp (ABSI) Form 10-Q for quarter ended June 30, 2025. No financial statements, MD&A, guidance, cash balance, burn, revenue, pipeline updates, or risk-factor changes are included in the provided text, limiting tradable insights.

Mentioned: Aug 12, 2025, 4:45 PM EDTConviction: 18 / 100
Source: ABSI 10-Q report for 2025-06-30

Current stance

Recommendationbuy
Authors1
Active decisions3
Latest price$7.56

Top authors on this asset

Investment decisions

ABSI
watch

ABSI
watch

ABSI
watch

ABSI
watch

ABSI
research_buy

Unlock full asset monitoring

Create an account to inspect complete asset history, trust-weighted rankings, and persisted evidence across authors, theses, and market events.